At the risk of sounding a bit mean, CareFusion (NYSE: CFN ) doesn't get all that much attention in the market. The company has a soli...
At the risk of sounding a bit mean, CareFusion (NYSE: CFN ) doesn't get all that much attention in the market. The company has a soli...
There are two relatively heated debates that bear directly on Amgen (Nasdaq: AMGN ) and its stock. First, is Amgen still really a biotech,...
It's a curious thing that investors' desire for short-term growth will often lead them to pay what looks like much too high a price...
This recent melt-up in the market has left relatively few undervalued opportunities in the med-tech sector. While there are still some bar...